US Stock MarketDetailed Quotes

IGMS IGM Biosciences

Watchlist
  • 17.140
  • -0.460-2.61%
Close Oct 31 16:00 ET
  • 17.140
  • 0.0000.00%
Post 16:01 ET
1.02BMarket Cap-4801P/E (TTM)

About IGM Biosciences Company

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firm’s product pipeline includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies, IGM-8444, which is an IgM antibody targeting Death Receptor 5 for the treatment of patients with solid and hematologic malignancies, and IGM-7354, which will target the delivery of IL-15 with the goal of inducing immune cell stimulation and proliferation. The company was founded in 2010 and is headquartered in Mountain View, CA.

Company Profile

SymbolIGMS
Company NameIGM Biosciences
Listing DateSep 18, 2019
Issue Price16.00
Founded2010
CEOMs. Mary Beth Harler
MarketNASDAQ
Employees224
Fiscal Year Ends12-31
Address325 East Middlefield Road
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94043
Phone1-650-965-7873

Company Executives

  • Name
  • Position
  • Salary
  • Mary Beth Harler
  • Director and Chief Executive Officer
  • --
  • Misbah Tahir
  • Chief Financial Officer
  • --
  • Lisa Lynn Decker, PhD
  • Chief Business Officer
  • --
  • Steven Weber
  • Principal Accounting Officer, Senior Vice President and Corporate Controller
  • --
  • Dr. William Strohl, PhD
  • Independent Director
  • 236.59K
  • Dr. M. Kathleen Behrens Wilsey, PhD
  • Independent Director
  • 178.30K
  • Dr. Felix J. Baker,PhD
  • Independent Director
  • 168.55K
  • Dr. Elizabeth H.Z. Thompson, PhD
  • Independent Director
  • 167.54K
  • Christina Teng Topsoe
  • Independent Director
  • 175.84K
  • Michael Lee
  • Independent Director
  • 166.09K
  • Dr. Julie Hambleton, M.D.
  • Independent Director
  • 204.09K
  • Jakob Haldor Topsoe
  • Independent Director
  • 166.09K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data